BLOG: Bringing uveitis treatment into the modern age | Ophthalmology Blogs |

The treatment of inflammatory ocular disease is becoming more exciting. In years past, the spectrum of available treatment for uveitis was topical steroids, more frequent topical steroids, subconjunctival steroids and systemic (you guessed it) steroids. The advent of immunomodulatory drugs such as methotrexate and TNF blockers such as Enbrel (etanercept, Amgen) has offered meaningful advances for select diagnoses, but typically these have required the guidance of a rheumatologist or uveitis specialist.

Now, a variety of drug delivery systems are undergoing development that may make it easier for general ophthalmologists to manage this type of chronic disease.

Let’s face it, the only thing worse than a patient having to take topical steroid drops is having to take them chronically. Compliance is just one problem. Another is the uniformity of dosing that comes from suspensions such as Pred Forte (prednisolone acetate ophthalmic suspension,

Curated from BLOG: Bringing uveitis treatment into the modern age | Ophthalmology Blogs |